What are the guideline sources, guidelines and references for Scleredema ?
Guideline sources The following summarized guidelines for the evaluation and management of scleredema are prepared by our editorial team based on guidelines from the European Academy of Dermatology and Venereology (EADV 2017). 1 Guidelines 1. Screening and diagnosis Diagnosis: Diagnose scleredema clinically. E Perform a histopathologic examination to confirm a definitive diagnosis. E 2. Medical management Indications for treatment: Do not initiate treatment in patients with type 1 scleredema, as it is self-limited and usually resolves in a short period of time. D Initiate treatment for an underlying condition in patients with types 2 and 3 scleredema. E Treatment options: https://web.pathway.md/diseases/recEdiN7gxHut6Vvy 1/2 6/24/23, 3:05 PM Scleredema Pathway Consider offering UV A-based management as first-line monotherapy in patients with scleroderma. E Offer methotrexate if UV A-based therapy fails. E Glycemic control: ensure better glucose control in patients with type 3 scleredema. E 3. Follow-up and surveillance Follow-up: follow-up patients with types 2 and 3 scleredema to screen for paraproteinemia and systemic complications. E References 1. R Knobler, P Moinzadeh, N Hunzelmann et al. European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2 Scleromyxedema, scleredema and nephrogenic systemic fibrosis. J Eur Acad Dermatol Venereol. 2017 Oct;31 10 1581 1594. Open https://web.pathway.md/diseases/recEdiN7gxHut6Vvy 2/2